Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:30 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Trial of Orencia in Patients With Myasthenia Gravis
NCT03059888 · Johns Hopkins University · EARLY_PHASE1 · terminated · last registry update 2019-11-22 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Mutual decision of sponsor and investigator due to logistical challenges” | – | Registry record, Johns Hopkins University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CD86 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-11-16Also stopped (withdrawn): University of California, Los Angeles, Abatacept + Placebo (NCT02053727)
- 2020-10-30Phase 3 first posted: University of Erlangen-Nürnberg Medical School, Prednisolone + Sulfasalazine (NCT04610476)
- 2020-10-20Phase 3 first posted: Daniel Benjamin, Infliximab + Abatacept (NCT04593940)
- 2020-10-01Results posted on the registry: Dr. Larry W. Moreland, TNF Antagonist (enbrel, humire, remicade, cimzia, symponi) + Abatacept (NCT02353780)
- 2020-10-01Also stopped (terminated): Dr. Larry W. Moreland, TNF Antagonist (enbrel, humire, remicade, cimzia, symponi) + Abatacept (NCT02353780)
- 2020-09-18Results posted on the registry: Emory University, Belatacept (NCT02560558)
- 2020-09-03Results posted on the registry: Bristol-Myers Squibb, Abatacept + Adalimumab (NCT02557100)
- 2020-07-20Also stopped (withdrawn): Beth Israel Deaconess Medical Center, Abatacept (NCT04477642)
- 2020-07-17Phase 3 first posted: University of Pennsylvania, Abatacept + Placebo (NCT04474847)
- 2020-06-17Results posted on the registry: Boston Children's Hospital, Abatacept + placebo (NCT01743131)
- 2020-06-04Results posted on the registry: AbbVie, Abatacept + Placebo for abatacept (0.9% Sodium Chloride Injection or Solution for Infusion) (NCT03086343)
- 2020-03-30Results posted on the registry: Christopher Bowlus, MD, abatacept (NCT02078882)
- 2020-03-23Also stopped (terminated): University of Chicago, Abatacept (NCT00739960)
- 2020-03-17Results posted on the registry: University of Chicago, Abatacept (NCT00739960)
- 2020-01-30Results posted on the registry: Allan D Kirk, MD, PhD, Belatacept + Sirolimus (NCT00565773)
- 2020-01-02Results posted on the registry: Bristol-Myers Squibb, Abatacept (NCT02915159)
- 2019-09-10Results posted on the registry: Columbia University, Belatacept + Tacrolimus (NCT02152345)
- 2019-07-10Phase 3 first posted: Nantes University Hospital, Belatacept 250 Milligram Intravenous Powder for Solution (NCT04013620)
- 2019-06-27Phase 3 first posted: Federal Research Institute of Pediatric Hematology, Oncology and Immunology, Preparative regimen (NCT04000698)
- 2019-06-18Results posted on the registry: Dinesh Khanna, MD, MS, Abatacept + Placebo (NCT02161406)
- 2019-05-02Also stopped (withdrawn): Duke University, Belatacept + Carfilzomib (NCT03805178)
- 2019-04-17Results posted on the registry: Columbia University, Abatacept (NCT02018042)
- 2019-04-17Results posted on the registry: Bristol-Myers Squibb, Process E Belatacept + Process C Belatacept (NCT02564497)
- 2019-04-08Results posted on the registry: Bristol-Myers Squibb, Abatacept + Methotrexate (NCT02504268)
- 2019-02-21Results posted on the registry: Oregon Health and Science University, Abatacept (NCT01279954)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision